Well-established as a major journal in today's rapidly advancing experimental and clinical research areas, Endocrine published full-length original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical (including proof of concept studies and clinical trials) research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority system and editorial decision. Invited and unsolicited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics are also published. Descriptions of single clinical cases and/or of small series of patients studies are not published unless considered of exceptional interest. Research letters and letters to the editor related or unrelated to recently published articles can be submitted. Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, and of HPA axis, pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology. An author-friendly journal, Endocrine provides contributors with fast turn-around (first decision average just over three weeks) and publication within four months of acceptance.